Avidity Biosciences
RNA
NASDAQ
IPO2020
about RNA
Avidity Biosciences discovers, develops, and delivers innovative therapeutic proteins and RNA-based solutions aimed at addressing diseases with significant unmet needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $70.31 | $72.05 | $69.88 | $7.17B | 70.80M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$1.21 | n/a | 2361.97 | -4448.71% | -4089.29% | 0% |